(1) Ferlay J, et al., GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No.5, Version 2.0. IARCPress, Lyon, 2004. Available at: http://www-dep.iarc.fr. Accessed May 2008.
(2) 2005 Cancer Register System (CRS) annual report, http://crs.cph.ntu.edu.tw/crs_c/annual.html. Accessed May 12, 2008.
(3) Ferlay J, et al., GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No.5, Version 2.0. IARCPress, Lyon, 2004. Available at: http://www-dep.iarc.fr. Accessed May 2008.
(4) 2005 Cancer Register System (CRS) annual report, http://crs.cph.ntu.edu.tw/crs_c/annual.html. Accessed May 12, 2008.
(5) Giordano TP, Kramer JR, Souchek J, Richardson P, El Serag HB. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. Arch Intern Med 2004;164:2349-2354.
(6) American Cancer Society. What is Liver Cancer? Available at: http://www.cancer.org/docroot/CRI/content/CRI_2_2_1X_What_is_liver_cancer_2 5.a sp. Accessed April 10, 2007.
(7) Adapted from National Cancer Institute. Adult Primary Liver Cancer. Available at: http://www.cancer.gov/cancertopics/pdq/treatment/adult-primary- liver/patient. Accessed May 8, 2008
| SOURCE Bayer HealthCare Pharmaceuticals Inc.; OnyxPharmaceuticals, Inc. Copyright©2008 PR Newswire. All rights reserved |